Sensei Biotherapeutics appoints Kristian Humer to board and audit committee

Sensei Biotherapeutics, Inc.

Effective July 30, 2021, Kristian Humer appointed as Class II director and audit committee member.
Humer previously Managing Director at Citigroup, now CFO/CBO of Viridian Therapeutics Inc.
Initial option grant of 16,667 shares vesting over 36 months; annual retainer of $35,000 plus $7,500 for audit committee.
No family relationships or arrangements with other directors/officers; standard indemnification agreement.
Eligible for additional annual option of 8,333 shares vesting over 12 months, starting at 2022 annual meeting.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kristian Humer

director

SNSE · Sensei Biotherapeutics, Inc.

Effective: 2021-07-30
Filed: August 2, 2021, 7:59 PM ET

Effective July 30, 2021, the board of directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) appointed Kristian Humer to serve as a director of the Company and as a member of the Company’s audit committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristian Humer was appointed as director at Sensei Biotherapeutics, Inc..

Action: appointed
Role: director

Exact text from the filing

Effective July 30, 2021, the board of directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) appointed Kristian Humer to serve as a director of the Company and as a member of the Company’s audit committee.

View on SEC.gov

Sensei Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-232433

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.